Table 3.
Comparison in bivariate analysis of potential risk factors influencing the risk of presenting with at least one flare during the first 6 months of follow up of patients with all data available
| No flare between M0 and M6 | At least 1 flare between M0 and M6 | p value | |
|---|---|---|---|
| Number of patients | 23 | 13 | / |
| DECT MSU volume knees (cm3) | 0.6 ± 1.2 | 1.1 ± 1.6 | 0.24 |
| DECT MSU volume feet (cm3) | 0.9 ± 0.8 | 2.1 ± 1.9 | 0.05 |
| Serum urate change between M0 and M6 (mg/dL) | 1.51 ± 2.03 | 1.50 ± 2.48 | 0.88 |
| Number of joints with the US double contour sign at M0 (/6) | 2.5 ± 0.9 | 2.9 ± 1.5 | 0.67 |
| Declared number of flares over the past year | 3 ± 4.4 | 4.2 ± 6.2 | 0.41 |
| Ongoing flare prophylaxis at M6 | 11 (47.8%) | 6 (46.2%) | 1 |
| Ongoing urate lowering therapy at M0 | 13 (56.5%) | 6 (46.2%) | 0.8 |
M0 month 0, M6 month 6, US ultrasonography, DECT dual-energy computed tomography, MSU, monosodium urate